Although the anti-tumor effect of IFN-γ in PC is a matter of debate, according to the outcomes of our research and above previous reports, we believe that IFN-γ still plays an anti-tumor role in inhibiting the development of PC and improving patient prognosis. The gene discussed is IFNG; the disease is pachyonychia congenita.